BE837211A - PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN - Google Patents

PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN

Info

Publication number
BE837211A
BE837211A BE6045314A BE6045314A BE837211A BE 837211 A BE837211 A BE 837211A BE 6045314 A BE6045314 A BE 6045314A BE 6045314 A BE6045314 A BE 6045314A BE 837211 A BE837211 A BE 837211A
Authority
BE
Belgium
Prior art keywords
gammaglobulin
tolerance
improving
intravenous injection
intravenous
Prior art date
Application number
BE6045314A
Other languages
French (fr)
Inventor
W Schneider
D Wolter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837211A publication Critical patent/BE837211A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE6045314A 1975-01-02 1975-12-30 PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN BE837211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (en) 1975-01-02 1975-01-02 Process for the production of intravenously tolerated gamma globulins

Publications (1)

Publication Number Publication Date
BE837211A true BE837211A (en) 1976-06-30

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6045314A BE837211A (en) 1975-01-02 1975-12-30 PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN

Country Status (20)

Country Link
JP (1) JPS5512001B2 (en)
AT (1) AT344883B (en)
AU (1) AU505416B2 (en)
BE (1) BE837211A (en)
CA (1) CA1058075A (en)
DD (1) DD121875A5 (en)
DE (1) DE2500076C3 (en)
DK (1) DK144679C (en)
EG (1) EG11987A (en)
ES (1) ES443982A1 (en)
FR (1) FR2296429A1 (en)
GB (1) GB1495159A (en)
IE (1) IE43449B1 (en)
IL (1) IL48766A (en)
IN (1) IN143525B (en)
NL (1) NL179824C (en)
PL (1) PL99599B1 (en)
SE (1) SE437470B (en)
SU (1) SU576898A3 (en)
ZA (1) ZA758050B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
JPS6016406B2 (en) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル Method for producing intravenously administrable gamma globulin and gamma globulin prepared thereby
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (en) * 1977-07-19 1983-05-06 株式会社ミドリ十字 Intravenous gamma globulin preparations
AT359641B (en) * 1978-09-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISTRABLE ANTIBODY-CONTAINING IMMUNOGLOBULIN PREPARATE
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (en) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (en) * 1983-05-02 1984-11-03 Pharmacia Ind PROCEDURE FOR PURIFICATION OF BIOLOGICALLY ACTIVE SUBSTANCES
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (en) * 1999-02-21 2000-09-14 Bernd Horst Meier Means for controlling the diffusion of injection solutions
DE10040707A1 (en) * 2000-08-17 2002-03-14 Braun Melsungen Ag Injectable aqueous medicament, containing colloid, e.g. hydroxyethyl starch, to modulate mobility, diffusion, pharmacokinetic and electrophoretic properties of active agent and improve effectiveness
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
CA2631195C (en) 2005-11-30 2016-04-05 Abbott Laboratories Monoclonal antibodies against amyloid beta protein and uses thereof
KR20080090408A (en) 2005-11-30 2008-10-08 아보트 러보러터리즈 Anti-abeta; globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
MX360403B (en) 2010-04-15 2018-10-31 Abbvie Inc Amyloid-beta binding proteins.
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (en) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (en) * 1971-07-16 1973-02-08 South African Inventions METHOD OF MANUFACTURING A PURIFIED GAMMA GLOBULIN
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (en) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
PL99599B1 (en) 1978-07-31
IE43449L (en) 1976-07-02
IL48766A0 (en) 1976-02-29
NL7514627A (en) 1976-07-06
SE437470B (en) 1985-03-04
AU505416B2 (en) 1979-11-22
ATA981675A (en) 1977-12-15
DK144679B (en) 1982-05-10
SE7514388L (en) 1976-07-05
CA1058075A (en) 1979-07-10
DE2500076B2 (en) 1979-02-22
DE2500076A1 (en) 1976-07-08
JPS5512001B2 (en) 1980-03-29
ZA758050B (en) 1976-12-29
EG11987A (en) 1981-12-31
DE2500076C3 (en) 1982-11-18
DK584375A (en) 1976-07-03
DD121875A5 (en) 1976-09-05
DK144679C (en) 1982-10-11
IL48766A (en) 1979-11-30
AU8792175A (en) 1977-07-14
AT344883B (en) 1978-08-10
ES443982A1 (en) 1977-07-16
SU576898A3 (en) 1977-10-15
IN143525B (en) 1977-12-17
IE43449B1 (en) 1981-02-25
FR2296429B1 (en) 1978-12-01
NL179824B (en) 1986-06-16
NL179824C (en) 1986-11-17
JPS5191321A (en) 1976-08-10
FR2296429A1 (en) 1976-07-30
GB1495159A (en) 1977-12-14

Similar Documents

Publication Publication Date Title
BE837211A (en) PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN
BE855192A (en) PROCESS FOR THE PRODUCTION OF SUBSTITUTED ALIPHATIC PHOSPHINICO-CARBOXYLIC ACIDS
FR2328689A1 (en) PROCESS FOR PREPARATION OF A-ARYLPROPIONIC ACIDS SUBSTITUTED ON THE CORE
FR2318131A1 (en) PROCESS FOR THE PRODUCTION OF OLEFINIC HYDROCARBONS
BE844344A (en) CYCLING PROCESS FOR THE FORMATION OF A CEPHEME CORE
LU79846A1 (en) PROCESS FOR THE PRODUCTION OF A GAMMA GLOBULIN PREPARATION
RO72349A (en) PROCESS FOR THE PREPARATION OF IMIDAZOLE DERIVATIVES WITH PHARMACOLOGICAL ACTION
FR2321465A1 (en) PROCESS FOR THE PREPARATION OF UNSATURATED HYDROCARBONS
FR2313447A1 (en) PROCESS FOR THE PRODUCTION OF AN ALCOHOLIC BEVERAGE
FR2316040A1 (en) PROCESS FOR MACHINING BY EROSIVE SPARKLING
FR2351922A1 (en) PROCESS FOR IMPROVING THE RESISTANCE OF A SEALING GLASS
BE851151R (en) PROCESS FOR IMPROVING THE TOLERANCE TO INTRAVENOUS INJECTION OF GAMMAGLOBULIN
RO66216A (en) PROCESS FOR THE PRODUCTION OF ENERGY
FR2317760A1 (en) PROCESS FOR THE PRODUCTION OF VACUUM BULBS
BE835023A (en) IMPROVED PROCESS FOR PRODUCING UROKINASE
BE846708A (en) PROCESS FOR THE PRODUCTION OF AN ALKANE-POLYOL
RO74667A (en) PROCESS FOR THE PREPARATION OF 7-BETHA (D-2-AMINO-2- (ALKYLESULFONYLEAMINOPHENYL) -ACETYLEAMINO) -3-ALCOXY-3-CEPHEM-4-CARBOXYLIC ACIDS
FR2299869A1 (en) PROCESS FOR THE PREPARATION OF ACIDS (
FR2329658A1 (en) NEW PROCESS FOR THE PREPARATION OF SUBSTITUTE IMIDAZOLES
BE865480A (en) PROCESS FOR THE PREPARATION OF NAPHTYLAMINOHYDROXYSULPHONIC ACIDS
PT64691B (en) PROCESS FOR THE PREPARATION OF 6,11-DI-HYDRO-11-OXO-DIBENZ / B, E / OXEPIN-ALKANOIC ACIDS
BE871961A (en) IMPROVED PROCESS FOR THE PRODUCTION OF ALKYLENE-GLYCOLS
FR2352879A1 (en) PROCESS FOR THE PRODUCTION OF
BE821725A (en) PROCESS FOR THE PREPARATION OF ALPHA-HYDROXY ANTHRAQUINONE-BETA-SULPHONIC ACIDS
BE841810A (en) PROCESS FOR ACCELERATING THE FILTRATION OF SLOW DISTILLATION TAR

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ARMOUR PHARMACEUTICAL CY

Effective date: 19891231